【信达生物(01801.HK)授出3.5万份购股权及49.775万股受限制股份】智通财经APP讯,信达生物(01801.HK)发布公告,2025年6月30日,公司根据2024年股份计划的条款向3名承授人授出3.5万份购股权,及向25名承授人授出49.775万股受限制股份,但须待承授人接纳。所有承授人均为集团非关联雇员(非高级管理层)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.